| Host: |
Rabbit |
| Applications: |
WB |
| Reactivity: |
Human |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-NAT1 (1-290) is suitable for use in Western Blot research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
PBS with 0.02% Sodium Azide, 50% Glycerol, pH7.3. |
| Purification: |
Affinity purification |
| Dilution Range: |
WB 1:500-1:2000 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
NAT1 |
| Gene ID: |
9 |
| Uniprot ID: |
ARY1_HUMAN |
| Immunogen Region: |
1-290 |
| Immunogen: |
Recombinant fusion protein containing a sequence corresponding to amino acids 1-290 of human NAT1 (NP_001153646.1). |
| Immunogen Sequence: |
MDIEAYLERIGYKKSRNKLD LETLTDILQHQIRAVPFENL NIHCGDAMDLGLEAIFDQVV RRNRGGWCLQVNHLLYWALT TIGFETTMLGGYVYSTPAKK YSTGMIHLLLQVTIDGRNYI VDAGFGRSYQMWQPLELISG KDQPQVPCVFRLTEENGFWY LDQIRREQYIPNEEFLHSDL LEDSKYRKIYSFTLKPRTIE DFESMNTYLQTSPSSVFTSK SFCSLQTPDGVHCLVGFTL |
| Function | Participates in the detoxification of a plethora of hydrazine and arylamine drugs. Catalyzes the N- or O-acetylation of various arylamine and heterocyclic amine substrates and is able to bioactivate several known carcinogens. |
| Protein Name | Arylamine N-Acetyltransferase 1Arylamide Acetylase 1Monomorphic Arylamine N-AcetyltransferaseMnatN-Acetyltransferase Type 1Nat-1 |
| Database Links | Reactome: R-HSA-156582Reactome: R-HSA-9753281 |
| Cellular Localisation | Cytoplasm |
| Alternative Antibody Names | Anti-Arylamine N-Acetyltransferase 1 antibodyAnti-Arylamide Acetylase 1 antibodyAnti-Monomorphic Arylamine N-Acetyltransferase antibodyAnti-Mnat antibodyAnti-N-Acetyltransferase Type 1 antibodyAnti-Nat-1 antibodyAnti-NAT1 antibodyAnti-AAC1 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
